Posted by Sean Solarzano on Nov 14th, 2024
Xenetic Biosciences, Inc., a biopharmaceutical company focusing on innovative immune-oncology technologies tackling challenging cancers, released its financial results for the third quarter of 2024 on November 13, 2024. The quarter...
More of this article »